DE60020855D1 - Bedingte immortalisierung von zellen - Google Patents

Bedingte immortalisierung von zellen

Info

Publication number
DE60020855D1
DE60020855D1 DE60020855T DE60020855T DE60020855D1 DE 60020855 D1 DE60020855 D1 DE 60020855D1 DE 60020855 T DE60020855 T DE 60020855T DE 60020855 T DE60020855 T DE 60020855T DE 60020855 D1 DE60020855 D1 DE 60020855D1
Authority
DE
Germany
Prior art keywords
cells
conditional immortalization
recombinant
conditionally
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60020855T
Other languages
English (en)
Other versions
DE60020855T2 (de
Inventor
Parmjit Jat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reneuron Ltd
Ludwig Institute for Cancer Research London
Original Assignee
Reneuron Ltd
Ludwig Institute for Cancer Research London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd, Ludwig Institute for Cancer Research London filed Critical Reneuron Ltd
Publication of DE60020855D1 publication Critical patent/DE60020855D1/de
Application granted granted Critical
Publication of DE60020855T2 publication Critical patent/DE60020855T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60020855T 1999-09-17 2000-09-18 Bedingte immortalisierung von zellen Expired - Lifetime DE60020855T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99307405 1999-09-17
EP99307405 1999-09-17
US09/663,537 US6399384B1 (en) 1999-09-17 2000-09-15 Conditional immortalization of cells
PCT/GB2000/003588 WO2001021790A1 (en) 1999-09-17 2000-09-18 Conditional immortalisation of cells

Publications (2)

Publication Number Publication Date
DE60020855D1 true DE60020855D1 (de) 2005-07-21
DE60020855T2 DE60020855T2 (de) 2006-05-04

Family

ID=26153574

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60020855T Expired - Lifetime DE60020855T2 (de) 1999-09-17 2000-09-18 Bedingte immortalisierung von zellen

Country Status (11)

Country Link
US (1) US6399384B1 (de)
EP (1) EP1212420B1 (de)
JP (1) JP2003510046A (de)
CN (1) CN1373804A (de)
AT (1) ATE297987T1 (de)
AU (1) AU757816B2 (de)
CA (1) CA2383253A1 (de)
DE (1) DE60020855T2 (de)
ES (1) ES2241652T3 (de)
IL (1) IL148008A0 (de)
WO (1) WO2001021790A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
GB9907243D0 (en) * 1999-03-29 1999-05-26 Reneuron Ltd Therapy
GB0005856D0 (en) * 2000-03-10 2000-05-03 Reneuron Ltd Genetic constructs
DE10019195B4 (de) * 2000-04-17 2006-03-09 Heart Biosystems Gmbh Reversible Immortalisierung
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) * 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20050074747A1 (en) * 2000-09-08 2005-04-07 Wadih Arap Biopanning and rapid analysis of selective interactive ligands (brasil)
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
EP1207196A1 (de) * 2000-10-27 2002-05-22 Societe Des Produits Nestle S.A. Immortalisierte pre-osteoblasten und verfahren zur deren herstellung
US20040176290A1 (en) * 2001-07-18 2004-09-09 Renata Pasqualini Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
GB0125773D0 (en) * 2001-10-26 2001-12-19 Reneuron Ltd Constructs
JPWO2003038076A1 (ja) * 2001-10-31 2005-02-24 株式会社レノメディクス研究所 不死化間葉系細胞及びその利用
ES2353665T3 (es) * 2002-03-15 2011-03-03 Duke University Ingeniería tisular.
US20040241808A1 (en) * 2003-04-14 2004-12-02 Renata Pasqualini Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
EP1664098A1 (de) * 2003-09-12 2006-06-07 Reneuron Limited Immortalisierung von säugetierzellen und therapeutische anwendungen für diese zellen
US20050193432A1 (en) * 2003-11-18 2005-09-01 Whitehead Institute For Biomedical Research Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof
ES2294650T3 (es) * 2004-09-30 2008-04-01 Reneuron Limited Linea celular.
WO2006113534A1 (en) * 2005-04-15 2006-10-26 The Johns Hopkins University Immortilization of cells including neuronal cells
ATE513034T1 (de) * 2005-12-16 2011-07-15 Ribovax Biotechnologies Sa Verfahren zur gewinnung immortalisierter antikörpersezernierender zellen
GB0822246D0 (en) 2008-12-05 2009-01-14 Reneuron Ltd Composition
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
EP2380905A1 (de) 2010-04-19 2011-10-26 Thrombotargets Europe, S.L. Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon
CN105176913A (zh) * 2015-09-23 2015-12-23 扬州大学 一种奶牛乳腺上皮细胞永生化方法
US20220025332A1 (en) * 2018-12-16 2022-01-27 Figene, Llc Therapeutic uses of gene edited fibroblasts
GB202005494D0 (en) 2020-04-15 2020-05-27 Reneuron Ltd Induced pluripotent cell comprising a contollable transgene for conditional immortalisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270191A (en) * 1988-04-12 1993-12-14 Massachusetts Institute Of Technology Method for manipulation of the cell types of eukaryotes
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
JPH10513343A (ja) 1994-12-19 1998-12-22 コールド スプリング ハーバー ラボラトリー テロメラーゼの蛋白質成分
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
SG94355A1 (en) 1996-10-01 2003-02-18 Geron Corp Human telomerase catalytic subunit
WO1998037181A2 (en) 1997-02-20 1998-08-27 Whitehead Institute For Biomedical Research Telomerase catalytic subunit gene and encoded protein

Also Published As

Publication number Publication date
DE60020855T2 (de) 2006-05-04
JP2003510046A (ja) 2003-03-18
CA2383253A1 (en) 2001-03-29
AU757816B2 (en) 2003-03-06
EP1212420A1 (de) 2002-06-12
ES2241652T3 (es) 2005-11-01
CN1373804A (zh) 2002-10-09
IL148008A0 (en) 2002-09-12
WO2001021790A1 (en) 2001-03-29
ATE297987T1 (de) 2005-07-15
US6399384B1 (en) 2002-06-04
AU7301500A (en) 2001-04-24
EP1212420B1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
DE60020855D1 (de) Bedingte immortalisierung von zellen
DK1280898T3 (da) Modificerede ES-celler og ES-cellespecifikt gen
DK1210411T3 (da) Sammensætninger og fremgangsmåder til forbedret celledyrkning
HK1091228A1 (en) Methods for making recombinant proteins using apoptosis inhibitors
ATE342275T1 (de) Vorübergehend-immortalisierte zellen zur verwendung in gentherapie
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
ATE391175T1 (de) Multidrug resistenz gen
DK1137808T3 (da) Fremgangsmåde til fremstilling af rekombinante celler
DE602005023181D1 (de) Lentivirusvektoren und deren verwendung
DK1032672T3 (da) DNA19355-polypeptid, en tumornekrosefaktor-homolog
ATE326537T1 (de) Schnell erzeugung von stabilen säugertier- zellinien mit gewinnung eines hohen gehalts von recombinanten proteine
DK1131408T3 (da) Celler, dyrkningsmetoder og deres anvendelse ved autolog transplantationsbehandling
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
FR2716205B1 (fr) Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
DE69515652D1 (de) Verwendung von dna oligomeren zur hemmung von hiv durch reduktion ribosomaler leserasterverschichtung
AR020208A1 (es) Construcciones de adn
DE69737597D1 (de) Vektoren zur inhibierung von viralem und tumorwachstum
BR0014489B1 (pt) processo de produÇço de adenovÍrus, e, kit.
DK0994955T3 (da) Öget produktion af secernerede proteiner med rekombinante gærceller
WO2000053759A8 (en) Expression of human alpha-fetoprotein in mammalian cells
MY136860A (en) Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
DE69939825D1 (de) Genetische transduktion von hämatopoietische vorläuferzellen
DE10083676T1 (de) Rekombinantes Enzym mit ausgezeichneter D-Aminosäureoxidaseaktivität sowie dessen Herstellung
WO1999060152A8 (en) Process for sialylating glycoproteins
DE69931615D1 (de) Varianten amylolytischer enzyme

Legal Events

Date Code Title Description
8364 No opposition during term of opposition